- Home
- Equipment
- usa maryland
- animal feeding
Refine by
Animal Feeding Equipment Supplied In Usa Maryland
5 equipment items found
Manufactured by:QIAGEN GmbH based inHilden, GERMANY
The mericon Campylobacter triple Kit is designed for the detection of Campylobacter jejuni, C. coli, and C. laridis in food and animal feed samples after enrichment. The mericon Campylobacter triple Kit can detect as few as 10 copies of C. jejuni, C. coli, or C. laridis DNA in a reaction and exhibits high specificity. No cross-reactivity was observed with other ...
Manufactured by:QIAGEN GmbH based inHilden, GERMANY
The mericon Campylobacter spp Kit is designed for the detection of several Campylobacter subspecies in food and animal feed samples after enrichment. The mericon Campylobacter spp Kit can detect as few as 10 copies of Campylobacter DNA in a reaction and exhibits high specificity for pathogens this genus. No cross-reactivity was observed with other pathogens using ...
Manufactured by:QIAGEN GmbH based inHilden, GERMANY
The mericon Campylobacter spp Kit is designed for the detection of several Campylobacter subspecies in food and animal feed samples after enrichment. The mericon Campylobacter spp Kit can detect as few as 10 copies of Campylobacter DNA in a reaction and exhibits high specificity for pathogens this genus. No cross-reactivity was observed with other pathogens using ...
Manufactured by:QIAGEN GmbH based inHilden, GERMANY
The mericon Campylobacter triple Kit is designed for the detection of Campylobacter jejuni, C. coli, and C. laridis in food and animal feed samples after enrichment. The mericon Campylobacter triple Kit can detect as few as 10 copies of C. jejuni, C. coli, or C. laridis DNA in a reaction and exhibits high specificity. No cross-reactivity was observed with other ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-2900, Tonix’s proprietary potentiated intranasal oxytocin is in the pre-Investigational New Drug (IND) stage as a candidate for the treatment of Prader-Willi syndrome (PWS) and non-organic failure to thrive disease. TNX-2900 has been granted Orphan Drug Designation (ODD) in the US by the FDA for the treatment of ...